Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Ovarian steroidogenesis (mmu04913)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Acot2
KLA  ATP  ATP+KLA
 NM_134188 acyl-CoA thioesterase 2 (Acot2), nuclear gene encoding mitochondrial protein, mRNA [NM_134188] KLA .46 .49 .37 .43 .34 .37 .53
ATP 1.02 1.15 .87 .99 .54 .37 .96
KLA/ATP .51 .46 .44 .49 .36 .34 .49
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Alox5
KLA  ATP  ATP+KLA
 NM_009662 arachidonate 5-lipoxygenase (Alox5), mRNA [NM_009662] KLA .83 .87 .88 .87 .71 .58 .21
ATP 1.03 1.03 1.14 1.21 .93 .55 .41
KLA/ATP .86 .85 .90 .97 .84 .61 .24
Bmp15
KLA  ATP  ATP+KLA
 NM_009757 bone morphogenetic protein 15 (Bmp15), mRNA [NM_009757] KLA 1.07 1.03 1.02 1.05 1.05 1.00 .99
ATP 1.02 1.02 1.05 1.03 .98 .97 .97
KLA/ATP .99 .94 1.03 .99 1.00 .96 1.02
Bmp6
KLA  ATP  ATP+KLA
 NM_007556 bone morphogenetic protein 6 (Bmp6), mRNA [NM_007556] KLA 1.03 1.02 .97 .97 1.01 1.01 1.00
ATP .99 1.00 .96 .97 .94 .98 1.01
KLA/ATP .98 1.06 1.04 1.01 1.02 1.00 .98
Cga
KLA  ATP  ATP+KLA
 NM_009889 glycoprotein hormones, alpha subunit (Cga), mRNA [NM_009889] KLA .98 .95 .95 1.01 1.01 .95 1.01
ATP .96 .89 .84 .90 1.03 .88 .98
KLA/ATP .99 .98 .83 .89 .98 .91 .86
Cyp11a1
KLA  ATP  ATP+KLA
 NM_019779 cytochrome P450, family 11, subfamily a, polypeptide 1 (Cyp11a1), nuclear gene encoding mitochondrial protein, mRNA [NM_019779] KLA 1.03 1.00 .96 1.04 1.05 1.03 .97
ATP 1.00 .99 .99 1.02 1.04 1.00 .99
KLA/ATP .99 1.03 1.05 .98 .95 .95 .96
Cyp17a1
KLA  ATP  ATP+KLA
 NM_007809 cytochrome P450, family 17, subfamily a, polypeptide 1 (Cyp17a1), mRNA [NM_007809] KLA 1.55 1.60 1.71 1.73 1.51 1.58 1.18
ATP .94 1.01 1.27 1.44 1.39 1.36 1.11
KLA/ATP 1.48 1.79 1.95 2.05 1.92 1.75 1.56
Cyp19a1
KLA  ATP  ATP+KLA
 NM_007810 cytochrome P450, family 19, subfamily a, polypeptide 1 (Cyp19a1), mRNA [NM_007810] KLA 1.04 .97 1.05 1.03 .99 1.02 .98
ATP 1.00 1.02 1.00 .93 .97 .99 1.08
KLA/ATP .99 .99 1.07 1.02 .98 .97 .98
Cyp1a1
KLA  ATP  ATP+KLA
 NM_009992 cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1), mRNA [NM_009992] KLA 1.07 .99 1.02 1.01 1.00 1.00 1.11
ATP .99 1.02 1.01 .95 .96 .94 1.09
KLA/ATP 1.01 1.03 .98 .96 .96 .95 1.51
Cyp1b1
KLA  ATP  ATP+KLA
 AK016699 adult male testis cDNA, RIKEN full-length enriched library, clone:4933406K16 product:cytochrome P450, 1b1, benz[a]anthracene inducible, full insert sequence. [AK016699] KLA 1.00 1.03 1.00 1.02 1.02 .97 1.03
ATP 1.00 1.04 1.03 1.13 1.04 1.05 1.02
KLA/ATP 1.06 1.03 .96 1.05 1.07 1.12 1.09
Cyp1b1
KLA  ATP  ATP+KLA
 NM_009994 cytochrome P450, family 1, subfamily b, polypeptide 1 (Cyp1b1), mRNA [NM_009994] KLA 1.02 .99 1.04 1.05 .98 1.00 1.07
ATP 1.05 1.01 1.05 1.19 1.09 2.31 5.32
KLA/ATP .99 1.02 1.05 1.06 1.14 1.39 3.15
Cyp2j11
KLA  ATP  ATP+KLA
 NM_001004141 cytochrome P450, family 2, subfamily j, polypeptide 11 (Cyp2j11), mRNA [NM_001004141] KLA .95 1.02 1.07 .95 .95 .92 .83
ATP .95 1.02 1.05 .93 .92 .90 1.00
KLA/ATP 1.05 .96 1.00 .97 .90 .82 .86
Cyp2j13
KLA  ATP  ATP+KLA
 NM_145548 cytochrome P450, family 2, subfamily j, polypeptide 13 (Cyp2j13), mRNA [NM_145548] KLA 1.01 .99 .98 1.00 .98 .96 .92
ATP .99 1.03 1.01 .98 .95 1.01 1.02
KLA/ATP .96 1.03 1.02 1.03 .96 .95 .96
Cyp2j5
KLA  ATP  ATP+KLA
 NM_010007 cytochrome P450, family 2, subfamily j, polypeptide 5 (Cyp2j5), mRNA [NM_010007] KLA 1.00 .99 1.05 1.01 1.00 1.06 1.06
ATP .99 1.00 1.03 1.09 1.00 1.03 1.01
KLA/ATP 1.03 .98 1.09 1.11 1.06 1.09 1.01
Cyp2j9
KLA  ATP  ATP+KLA
 NM_028979 cytochrome P450, family 2, subfamily j, polypeptide 9 (Cyp2j9), mRNA [NM_028979] KLA .84 .88 .97 .91 .75 .66 .66
ATP 1.10 .98 .99 .92 .90 .73 .64
KLA/ATP .88 .95 .93 .86 .80 .78 .59
Fshb
KLA  ATP  ATP+KLA
 NM_008045 follicle stimulating hormone beta (Fshb), mRNA [NM_008045] KLA 1.05 1.05 1.01 .98 1.05 1.03 1.07
ATP 1.02 1.01 1.02 .94 1.02 1.02 .96
KLA/ATP 1.10 1.03 .99 1.00 1.07 1.06 .98
Fshr
KLA  ATP  ATP+KLA
 NM_013523 follicle stimulating hormone receptor (Fshr), mRNA [NM_013523] KLA .98 1.03 .89 .95 .99 1.01 .98
ATP 1.01 1.03 1.02 .96 .95 .97 1.04
KLA/ATP .93 .94 1.06 .97 .92 .93 1.03
Gdf9
KLA  ATP  ATP+KLA
 NM_008110 growth differentiation factor 9 (Gdf9), mRNA [NM_008110] KLA 1.40 1.44 1.41 1.63 1.46 1.84 1.22
ATP .91 .79 1.37 3.45 3.47 3.87 1.19
KLA/ATP 1.34 1.31 2.19 4.40 6.50 6.91 1.54
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Hsd17b1
KLA  ATP  ATP+KLA
 NM_010475 hydroxysteroid (17-beta) dehydrogenase 1 (Hsd17b1), mRNA [NM_010475] KLA .85 .93 .83 .86 .82 .84 .92
ATP 1.11 1.11 1.02 1.96 1.92 1.07 .99
KLA/ATP .88 .92 .89 1.56 2.01 1.13 1.34
Hsd17b2
KLA  ATP  ATP+KLA
 NM_008290 hydroxysteroid (17-beta) dehydrogenase 2 (Hsd17b2), mRNA [NM_008290] KLA .99 1.05 .95 1.05 1.04 1.04 .97
ATP 1.03 .98 .98 1.03 .97 .99 1.06
KLA/ATP 1.10 1.01 1.01 1.03 1.02 .97 1.03
Hsd17b7
KLA  ATP  ATP+KLA
 NM_010476 hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7), mRNA [NM_010476] KLA .87 .86 .78 .85 .86 .76 .77
ATP 1.05 .94 1.22 .87 .69 .67 1.48
KLA/ATP .88 .76 .91 .70 .53 .34 .36
Hsd3b1
KLA  ATP  ATP+KLA
 NM_008293 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (Hsd3b1), mRNA [NM_008293] KLA .98 .97 .93 .92 1.00 .98 .95
ATP .93 1.01 1.00 1.04 .94 1.01 .88
KLA/ATP 1.01 .92 1.06 .98 1.03 .95 .97
Hsd3b2
KLA  ATP  ATP+KLA
 ENSMUST00000107022 ens|3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3- beta-HSD II) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (E KLA 1.06 .89 .93 .99 1.00 1.03 .96
ATP .94 1.03 .96 .91 .94 1.01 .93
KLA/ATP .93 1.01 .99 1.02 1.00 1.05 1.01
Hsd3b2
KLA  ATP  ATP+KLA
 NM_153193 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (Hsd3b2), mRNA [NM_153193] KLA 1.00 .99 1.00 1.05 .97 1.00 1.07
ATP .99 .99 .97 1.07 1.02 .99 1.01
KLA/ATP 1.02 1.07 .96 .98 1.02 1.08 .98
Hsd3b4
KLA  ATP  ATP+KLA
 NM_001111336 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 (Hsd3b4), transcript variant 1, mRNA [NM_001111336] KLA 1.01 1.03 .98 1.02 1.03 1.00 .92
ATP 1.06 1.06 1.03 .94 1.06 .96 .97
KLA/ATP 1.04 1.04 1.10 .94 .94 .98 .97
Hsd3b4
KLA  ATP  ATP+KLA
 NM_008294 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 (Hsd3b4), transcript variant 2, mRNA [NM_008294] KLA 1.06 1.09 1.11 1.13 1.04 1.13 1.12
ATP 1.00 .96 1.24 1.06 1.11 1.04 1.12
KLA/ATP 1.06 1.05 1.15 1.15 1.16 1.14 1.12
Hsd3b5
KLA  ATP  ATP+KLA
 NM_008295 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 (Hsd3b5), mRNA [NM_008295] KLA 1.00 .97 1.10 .92 .98 1.05 1.09
ATP 1.02 .95 .99 .95 .97 .93 .99
KLA/ATP .96 1.06 1.01 1.03 1.02 1.00 1.00
Hsd3b6
KLA  ATP  ATP+KLA
 NM_013821 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 6 (Hsd3b6), mRNA [NM_013821] KLA 1.06 1.09 1.05 1.02 .98 1.09 1.04
ATP 1.03 .96 1.05 1.01 1.02 1.00 1.04
KLA/ATP 1.02 1.02 1.06 1.03 1.04 1.14 1.06
Igf1
KLA  ATP  ATP+KLA
 AK050118 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730016P09 product:unclassifiable, full insert sequence. [AK050118] KLA .13 .14 .15 .16 .22 .34 .48
ATP 1.78 2.05 1.37 .72 .34 .41 .58
KLA/ATP .24 .45 .50 .24 .20 .26 .68
Igf1
KLA  ATP  ATP+KLA
 NM_010512 insulin-like growth factor 1 (Igf1), transcript variant 1, mRNA [NM_010512] KLA .84 .78 .76 .67 .54 .48 .59
ATP .97 .98 1.13 1.13 1.03 .88 .89
KLA/ATP .82 .81 .93 .86 .83 .65 .89
Igf1
KLA  ATP  ATP+KLA
 NM_184052 insulin-like growth factor 1 (Igf1), transcript variant 2, mRNA [NM_184052] KLA .77 .82 .76 .65 .60 .52 .69
ATP 1.01 1.07 .98 1.06 1.03 .78 .94
KLA/ATP .89 .86 .77 .80 .75 .65 .89
Igf1r
KLA  ATP  ATP+KLA
 NM_010513 insulin-like growth factor I receptor (Igf1r), mRNA [NM_010513] KLA 1.32 1.32 1.08 .91 .55 .48 .45
ATP 1.03 1.06 1.06 1.29 1.31 1.45 .47
KLA/ATP 1.30 1.37 1.11 1.00 .93 1.02 .45
Ins1
KLA  ATP  ATP+KLA
 NM_008386 insulin I (Ins1), mRNA [NM_008386] KLA 1.00 .99 .99 1.03 1.01 .98 1.06
ATP .97 1.03 1.00 1.03 .99 1.07 1.05
KLA/ATP 1.03 .93 .98 1.04 1.07 1.03 1.01
Ins2
KLA  ATP  ATP+KLA
 NM_008387 insulin II (Ins2), mRNA [NM_008387] KLA .99 1.00 1.00 1.01 1.00 1.02 1.00
ATP 1.01 .99 1.00 1.00 .98 .99 1.01
KLA/ATP .99 1.01 1.00 .98 .99 .99 .98
Insr
KLA  ATP  ATP+KLA
 NM_010568 insulin receptor (Insr), mRNA [NM_010568] KLA .75 .81 .77 .69 .69 .69 .83
ATP 1.07 1.06 .88 .79 .73 .77 .83
KLA/ATP .80 .80 .72 .71 .64 .64 .70
Ldlr
KLA  ATP  ATP+KLA
 NM_010700 low density lipoprotein receptor (Ldlr), mRNA [NM_010700] KLA 2.17 2.00 2.07 1.87 1.38 .78 1.00
ATP .98 .87 1.53 1.14 1.01 1.52 1.60
KLA/ATP 1.86 1.76 2.52 1.55 1.59 .84 .82
Ldlr
KLA  ATP  ATP+KLA
 Z19521 gb|M.musculus Ldlr mRNA encoding low density lipoprotein receptor. [Z19521] KLA 1.94 1.93 2.24 2.01 1.73 1.08 1.26
ATP 1.12 1.21 1.47 1.65 1.28 1.45 1.67
KLA/ATP 2.22 2.28 2.17 2.27 1.50 1.13 1.29
Lhb
KLA  ATP  ATP+KLA
 AK138425 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230101A12 product:luteinizing hormone beta, full insert sequence [AK138425] KLA 1.06 1.01 1.02 .98 1.00 1.07 .91
ATP 1.02 1.04 .91 .96 .90 1.05 .95
KLA/ATP .98 .96 1.01 1.03 1.04 1.00 1.09
Lhb
KLA  ATP  ATP+KLA
 NM_008497 luteinizing hormone beta (Lhb), mRNA [NM_008497] KLA 1.16 1.26 1.24 1.20 1.29 1.29 1.23
ATP 1.01 1.01 1.12 1.19 1.22 1.21 1.23
KLA/ATP 1.12 1.12 1.33 1.53 1.47 1.42 1.44
Lhcgr
KLA  ATP  ATP+KLA
 NM_013582 luteinizing hormone/choriogonadotropin receptor (Lhcgr), mRNA [NM_013582] KLA .98 1.06 .99 .95 1.01 1.00 1.04
ATP 1.01 .95 1.00 1.04 1.00 1.03 1.00
KLA/ATP 1.04 1.02 .97 1.01 1.03 1.04 .98
Mm.18893
9
KLA  ATP  ATP+KLA
 6754247 Unknown KLA .71 .85 .76 .78 .76 .81 .90
ATP 1.13 1.21 1.21 2.93 3.64 1.24 .96
KLA/ATP .77 .82 .96 2.56 4.66 1.65 1.50
Mm.26915
KLA  ATP  ATP+KLA
 51921286 Unknown KLA 1.02 1.03 .96 1.11 1.05 .96 .96
ATP 1.02 1.00 .98 1.06 1.04 .99 1.08
KLA/ATP .96 .94 1.06 1.00 1.02 1.00 1.03
Mm.27574
2
KLA  ATP  ATP+KLA
 112983655 Unknown KLA 1.35 1.16 .94 .85 .45 .33 .31
ATP .90 .86 1.17 1.09 1.18 1.21 .38
KLA/ATP 1.12 1.22 1.19 .91 .90 .83 .33
Mm.33050
7
KLA  ATP  ATP+KLA
 67906182 Unknown KLA .94 .98 .99 1.03 1.05 1.07 .98
ATP .95 1.02 .97 .98 .99 1.05 1.02
KLA/ATP 1.02 1.05 1.01 1.03 .99 .98 .97
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Pla2g4a
KLA  ATP  ATP+KLA
 NM_008869 phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] KLA 3.93 4.49 4.86 6.40 6.44 3.10 1.68
ATP 1.13 1.36 1.27 1.30 1.02 5.37 1.47
KLA/ATP 3.64 4.45 4.76 7.11 2.96 4.08 2.60
Pla2g4b
KLA  ATP  ATP+KLA
 NM_145378 phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] KLA 1.09 1.18 .95 1.01 .97 .97 .77
ATP 1.05 1.14 1.28 .94 .88 1.18 .70
KLA/ATP 1.23 1.43 1.21 1.02 1.15 1.16 .78
Pla2g4c
KLA  ATP  ATP+KLA
 AK145339 1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] KLA 1.09 1.21 1.33 1.17 1.26 1.30 1.05
ATP .97 1.06 1.00 .98 .98 .98 1.05
KLA/ATP 1.19 1.16 1.18 1.13 1.04 1.02 1.06
Pla2g4c
KLA  ATP  ATP+KLA
 NM_001004762 phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] KLA .93 1.00 .94 .93 .94 .94 .96
ATP .98 .96 1.13 .97 .99 .89 .96
KLA/ATP 1.01 1.01 1.07 1.01 .94 1.01 .92
Pla2g4e
KLA  ATP  ATP+KLA
 AK049063 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] KLA 1.03 1.09 1.01 1.01 1.06 .94 1.05
ATP 1.03 1.00 1.06 1.01 .96 1.05 1.05
KLA/ATP .98 1.00 1.01 .98 1.03 .95 1.01
Pla2g4e
KLA  ATP  ATP+KLA
 NM_177845 phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] KLA .97 .95 1.01 .97 1.02 1.03 1.05
ATP .98 .99 1.00 1.10 .98 1.00 1.02
KLA/ATP 1.05 .93 .96 1.03 1.08 1.05 .99
Pla2g4f
KLA  ATP  ATP+KLA
 NM_001024145 phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] KLA 1.08 .99 1.04 1.02 1.04 .98 1.01
ATP .99 1.04 .99 1.03 1.12 1.01 1.25
KLA/ATP .97 1.04 1.10 1.06 1.04 1.03 1.03
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Ptgs2
KLA  ATP  ATP+KLA
 NM_011198 prostaglandin-endoperoxide synthase 2 (Ptgs2), mRNA [NM_011198] KLA 181.04 220.88 218.58 132.79 103.05 22.69 18.02
ATP 2.47 9.45 52.13 208.62 271.22 306.11 6.86
KLA/ATP 233.39 387.29 617.86 ###.## 608.44 290.80 112.22
Scarb1
KLA  ATP  ATP+KLA
 NM_016741 scavenger receptor class B, member 1 (Scarb1), mRNA [NM_016741] KLA .62 .60 .60 .51 .45 .40 .48
ATP 1.04 1.14 .68 .89 .53 .46 .82
KLA/ATP .73 .67 .40 .55 .34 .30 .39
Star
KLA  ATP  ATP+KLA
 NM_011485 steroidogenic acute regulatory protein (Star), nuclear gene encoding mitochondrial protein, mRNA [NM_011485] KLA .99 .97 .99 1.00 .99 1.02 1.01
ATP 1.04 .94 .98 1.00 1.67 1.51 1.04
KLA/ATP 1.03 .99 1.01 1.03 1.77 1.56 1.09